- Pipeline - Molecular Partners
Explore Molecular Partners' innovative DARPin platform and its diverse therapeutic candidates targeting oncology and other diseases
- PIONEERING DARPin THERAPEUTICS - Molecular Partners
The Molecular Partners team is unique because we share a common vision and combine our diverse experiences and skill sets to achieve our goals
- Molecular Partners Reports Q3 2025 Financial Results and Clinical . . .
Molecular Partners presented preclinical data in April at the American Association for Cancer Research (AACR) Annual Meeting 2025, showing high tumor uptake, promising efficacy and a favorable safety profile for MP0712 in mouse models matching clinically-relevant DLL3 expression levels
- About Us - Molecular Partners
Our team collaborates with world-class partners to develop innovative treatments for cancer and serious diseases
- The DARPin Platform - Molecular Partners
The binding surfaces of a DARPin exert a unique molecular ‘grip’ on their targets, which can allow targeting of certain proteins that other biologic modalities like antibodies struggle with
- Molecular Partners Reports Highlights from Q4 2024 and Key Financials . . .
In October 2024, Molecular Partners raised approximately $20 million from both existing and new investors, such as HBM Partners, a leading healthcare investor based in Switzerland
- Updated Results from the Ongoing Phase 1 2a Study of MP0533, a Tetra . . .
B: consultant of Servier, Astellas, Pfizer MD:99981231160000-0800consultant for Molecular Partners AG, Debiopharm Int SA, Aurealis OY CA, EF, PBa, MS, VK, and PL: employees and stockholders of Molecular Partners MS: research support from Amgen, BMS Celgene, Gilead Kite, Johnson Johnson, Miltenyi, Novartis, Roche, Seattle Genetics, Taked
- Allergan and Molecular Partners Enter into Exclusive Alliance
Molecular Partners has established alliances with Allergan and Janssen and other pharmaceutical companies The company is backed by a strong syndicate of investors and holds a strong patent estate covering all DARPin applications
|